{"count":10,"index":{"built_at":"2026-07-28T02:31:49.043830+00:00","public_records":55311,"revision":"37dc1fdebe4e64cfa1231154"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: CYP1A2 in the context of sleep"},"results":[{"answer":"The provided context does not contain direct evidence linking CYP1A2 genotype to sleep outcomes. CYP1A2 is primarily known for metabolizing caffeine; variants (e.g., rs762551) affect caffeine clearance. Fast metabolizers (C allele) break down caffeine more quickly, which could theoretically reduce caffeine's sleep-disrupting effects. Slow metabolizers (A allele) have higher caffeine levels and may be more sensitive to caffeine, potentially impairing sleep quality. However, these effects are indirect and heavily dependent on individual caffeine intake. Evidence for a direct association between CYP1A2 and sleep disorders is weak, mostly based on observational studies or mechanistic reasoning. No robust clinical trials support personalized sleep recommendations based solely on CYP1A2 genotype. Other factors such as chronotype, stress, sleep hygiene, and overall health are far more influential. Therefore, the utility of a DNA test for CYP1A2 in the context of sleep is limited. The evidence is rated as 'unclear'.","area":"gesundheit","canonical_id":"gesundheit:canonical-3df2aa59df7ab644a1fcd14f","id":"public-211c1c30b83410c5e41f5822","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of sleep","score":21.96911181,"snippet":"The provided context does not contain direct evidence linking CYP1A2 genotype to sleep outcomes. CYP1A2 is primarily known for metabolizing caffeine; variants (e.g., rs762551) affect caffeine clearance. Fast metabolizers (C allele) break down caffeine more quickly, which could theoretically reduce caffeine's sleep-disrupting effects. Slow metabolizers (A allele) have higher caffeine levels and may be more sensitive to caffeine, potentially impairing sleep quality. However, these effects are indirect and heavily dependent on individual caffeine intake. Evidence for a direct association between CYP1A2 and sleep disorders is weak, mostly based on observational studies or mechanistic reasoning. ","sources":[],"title":"Evidence check: CYP1A2 in the context of sleep","url":"https://tikki.wiki/wissen/gesundheit/frage/public-211c1c30b83410c5e41f5822/evidence-check-cyp1a2-in-the-context-of-sleep/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The relevance of CYP1A2 for sleep is indirect and moderately supported. CYP1A2 is the primary enzyme metabolizing caffeine. The common SNP rs762551 (CYP1A2*1F) classifies individuals as fast or slow caffeine metabolizers. Slow metabolizers maintain higher caffeine blood levels longer, which can impair sleep – especially delayed sleep onset and reduced deep sleep. However, there is no strong evidence that CYP1A2 variants directly regulate sleep independent of caffeine. The association is plausible but effect sizes are small and heavily lifestyle-dependent. MyBody-X includes CYP1A2 in its DNA test, but results are lifestyle information, not medical diagnosis. If you have sleep issues, first evaluate caffeine intake, sleep hygiene, and stress. A genetic test alone does not replace medical evaluation. Evidence: human-moderate (caffeine metabolism-sleep association), but not for direct sleep regulation.","area":"gesundheit","canonical_id":"gesundheit:canonical-4a5902ec35a0a90d25462833","id":"public-d88ab2135adaf9124a914202","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of Schlaf","score":21.90659046,"snippet":"The relevance of CYP1A2 for sleep is indirect and moderately supported. CYP1A2 is the primary enzyme metabolizing caffeine. The common SNP rs762551 (CYP1A2*1F) classifies individuals as fast or slow caffeine metabolizers. Slow metabolizers maintain higher caffeine blood levels longer, which can impair sleep – especially delayed sleep onset and reduced deep sleep. However, there is no strong evidence that CYP1A2 variants directly regulate sleep independent of caffeine. The association is plausible but effect sizes are small and heavily lifestyle-dependent. MyBody-X includes CYP1A2 in its DNA test, but results are lifestyle information, not medical diagnosis. If you have sleep issues, first ev","sources":[],"title":"Evidence check: CYP1A2 in the context of Schlaf","url":"https://tikki.wiki/wissen/gesundheit/frage/public-d88ab2135adaf9124a914202/evidence-check-cyp1a2-in-the-context-of-schlaf/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP1A2 is a key enzyme in caffeine metabolism. Variants like rs762551 ('fast' vs. 'slow' metabolizers) influence how quickly caffeine is cleared. In the context of fatigue, caffeine is often used as a stimulant, but its effect depends on tolerance, sleep quality, and timing, not just genotype. No strong evidence directly links CYP1A2 variants to general fatigue. Some studies suggest modest differences in caffeine sensitivity, but effect sizes are small and not clinically actionable. For chronic fatigue, medical workup (iron, thyroid, sleep disorders) is far more relevant. A DNA test for CYP1A2 offers only speculative guidance. Evidence: mechanistic/unclear; no robust clinical trials confirm a fatigue link.","area":"gesundheit","canonical_id":"gesundheit:canonical-9db51429088813073ce8e0b8","id":"public-255af74be4179bf30d1563a0","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of Müdigkeit","score":21.5036175,"snippet":"CYP1A2 is a key enzyme in caffeine metabolism. Variants like rs762551 ('fast' vs. 'slow' metabolizers) influence how quickly caffeine is cleared. In the context of fatigue, caffeine is often used as a stimulant, but its effect depends on tolerance, sleep quality, and timing, not just genotype. No strong evidence directly links CYP1A2 variants to general fatigue. Some studies suggest modest differences in caffeine sensitivity, but effect sizes are small and not clinically actionable. For chronic fatigue, medical workup (iron, thyroid, sleep disorders) is far more relevant. A DNA test for CYP1A2 offers only speculative guidance. Evidence: mechanistic/unclear; no robust clinical trials confirm ","sources":[],"title":"Evidence check: CYP1A2 in the context of Müdigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-255af74be4179bf30d1563a0/evidence-check-cyp1a2-in-the-context-of-muedigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The question about CYP1A2 in the context of fatigue is understandable because CYP1A2 is a key enzyme in caffeine metabolism, and caffeine is commonly used to combat fatigue. However, the provided context contains no direct studies or data linking CYP1A2 to fatigue. The available information covers other genes (VDR, TCF7L2, BMAL1, ADRB3, ESR1, CYP2C19) and is not transferable. From general knowledge: CYP1A2 polymorphisms (e.g., rs762551) affect caffeine clearance – “fast metabolizers” break down caffeine quickly, potentially shortening its alertness effect; “slow metabolizers” experience prolonged effects but also higher risk of side effects like jitteriness or sleep disruption. A direct causal link between CYP1A2 genotype and fatigue is not established. Fatigue is multifactorial (sleep quality, stress, diet, exercise, hormones). A single genetic test does not provide clinically actionable information. The evidence level is best described as “mechanistic” or “unclear.” No medical guidelines recommend CYP1A2 testing for fatigue assessment. Consumers should not rely on such single markers and should seek medical evaluation for persistent fatigue.","area":"gesundheit","canonical_id":"gesundheit:canonical-4e1c2cd3f5f3d1de08d3edcb","id":"public-54d8c001aac4adfdd10ee4b4","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of fatigue","score":21.30820042,"snippet":"The question about CYP1A2 in the context of fatigue is understandable because CYP1A2 is a key enzyme in caffeine metabolism, and caffeine is commonly used to combat fatigue. However, the provided context contains no direct studies or data linking CYP1A2 to fatigue. The available information covers other genes (VDR, TCF7L2, BMAL1, ADRB3, ESR1, CYP2C19) and is not transferable. From general knowledge: CYP1A2 polymorphisms (e.g., rs762551) affect caffeine clearance – “fast metabolizers” break down caffeine quickly, potentially shortening its alertness effect; “slow metabolizers” experience prolonged effects but also higher risk of side effects like jitteriness or sleep disruption. A direct caus","sources":[],"title":"Evidence check: CYP1A2 in the context of fatigue","url":"https://tikki.wiki/wissen/gesundheit/frage/public-54d8c001aac4adfdd10ee4b4/evidence-check-cyp1a2-in-the-context-of-fatigue/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The role of CYP1A2 in weight loss is not strongly supported by evidence. CYP1A2 encodes an enzyme that metabolizes caffeine. Some studies suggest that genetic variants (e.g., rs762551) influence caffeine clearance and may modulate the thermogenic effect of caffeine, but findings are inconsistent. Most evidence is mechanistic or from small observational studies; large randomized trials are lacking. Lifestyle factors (caffeine intake, sleep, exercise) likely override any small genetic effect. Direct weight loss recommendations based solely on CYP1A2 genotype are not evidence-based. Consumers should be cautious of DTC tests that oversimplify 'metabolic types' for marketing. A holistic approach including diet, physical activity, and medical supervision remains essential.","area":"gesundheit","canonical_id":"gesundheit:canonical-0166acb84e23db2aa54ea6b8","id":"public-58a932cfe5ed8bdee40a2db4","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of weight loss","score":21.01308381,"snippet":"The role of CYP1A2 in weight loss is not strongly supported by evidence. CYP1A2 encodes an enzyme that metabolizes caffeine. Some studies suggest that genetic variants (e.g., rs762551) influence caffeine clearance and may modulate the thermogenic effect of caffeine, but findings are inconsistent. Most evidence is mechanistic or from small observational studies; large randomized trials are lacking. Lifestyle factors (caffeine intake, sleep, exercise) likely override any small genetic effect. Direct weight loss recommendations based solely on CYP1A2 genotype are not evidence-based. Consumers should be cautious of DTC tests that oversimplify 'metabolic types' for marketing. A holistic approach ","sources":[],"title":"Evidence check: CYP1A2 in the context of weight loss","url":"https://tikki.wiki/wissen/gesundheit/frage/public-58a932cfe5ed8bdee40a2db4/evidence-check-cyp1a2-in-the-context-of-weight-loss/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP1A2 is a phase I enzyme primarily known for metabolizing caffeine and certain drugs. A direct, clinically meaningful link to blood sugar regulation is not well established. Some observational studies suggest that slow caffeine metabolizers (due to CYP1A2 variants) may experience slightly altered glucose tolerance, likely mediated by caffeine's acute effect on insulin sensitivity. However, the effects are small, inconsistent, and not proven causal. A DNA test for CYP1A2 alone is not actionable for blood sugar management. Established factors like diet, exercise, sleep, and possibly continuous glucose monitoring are far more relevant. The evidence level is mechanistic/unclear; marketing claims labeling CYP1A2 a 'blood sugar gene' are overblown.","area":"gesundheit","canonical_id":"gesundheit:canonical-0ab30a8f7eab2bcc3c305912","id":"public-01d5bd8746fa6e82e8048334","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of blood sugar","score":21.01177895,"snippet":"CYP1A2 is a phase I enzyme primarily known for metabolizing caffeine and certain drugs. A direct, clinically meaningful link to blood sugar regulation is not well established. Some observational studies suggest that slow caffeine metabolizers (due to CYP1A2 variants) may experience slightly altered glucose tolerance, likely mediated by caffeine's acute effect on insulin sensitivity. However, the effects are small, inconsistent, and not proven causal. A DNA test for CYP1A2 alone is not actionable for blood sugar management. Established factors like diet, exercise, sleep, and possibly continuous glucose monitoring are far more relevant. The evidence level is mechanistic/unclear; marketing clai","sources":[],"title":"Evidence check: CYP1A2 in the context of blood sugar","url":"https://tikki.wiki/wissen/gesundheit/frage/public-01d5bd8746fa6e82e8048334/evidence-check-cyp1a2-in-the-context-of-blood-sugar/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP1A2's role in weight loss is indirect, primarily through caffeine metabolism. CYP1A2 is the main enzyme breaking down caffeine. Caffeine can transiently boost metabolism and fat oxidation, but the effect is modest and highly individual. Slow metabolizers (e.g., CYP1A2*1F variants) may experience stronger side effects like insomnia or jitters, which can hinder consistent diet and exercise. No strong evidence links CYP1A2 variants directly to weight loss success. The evidence is mostly mechanistic; human studies are mixed and often confounded by lifestyle factors. For sustainable weight loss, calorie deficit, physical activity, and sleep hygiene are far more impactful than this single gene. Caution: high caffeine intake can lead to tolerance, anxiety, and cardiovascular strain. Do not rely on genetic tests for weight loss advice without considering overall context.","area":"gesundheit","canonical_id":"gesundheit:canonical-c61f84b3d805606d132f8291","id":"public-81160dde8360d910c9136965","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of Abnehmen","score":20.9438014,"snippet":"CYP1A2's role in weight loss is indirect, primarily through caffeine metabolism. CYP1A2 is the main enzyme breaking down caffeine. Caffeine can transiently boost metabolism and fat oxidation, but the effect is modest and highly individual. Slow metabolizers (e.g., CYP1A2*1F variants) may experience stronger side effects like insomnia or jitters, which can hinder consistent diet and exercise. No strong evidence links CYP1A2 variants directly to weight loss success. The evidence is mostly mechanistic; human studies are mixed and often confounded by lifestyle factors. For sustainable weight loss, calorie deficit, physical activity, and sleep hygiene are far more impactful than this single gene.","sources":[],"title":"Evidence check: CYP1A2 in the context of Abnehmen","url":"https://tikki.wiki/wissen/gesundheit/frage/public-81160dde8360d910c9136965/evidence-check-cyp1a2-in-the-context-of-abnehmen/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP1A2 is the primary enzyme responsible for caffeine metabolism. The common variant rs762551 (often called *1F) classifies individuals as fast (AA) or slow (AC/CC) metabolizers. In sports, it is hypothesized that fast metabolizers gain greater ergogenic benefit from caffeine, while slow metabolizers may face increased side effects like palpitations or sleep disruption. However, the evidence is mixed: some studies report improved endurance performance in AA homozygotes, but others find no genotype-dependent effect. Additionally, CYP1A2 activity is influenced by smoking, medications, and diet, which limits the predictive value of a single DNA test. Recent reviews (e.g., PMID: 30926990) conclude that current data do not support personalized caffeine dosing based solely on CYP1A2 genotype. For consumers, this means the test may offer a suggestive clue but not a reliable action plan. Safety note: high caffeine intake can be harmful regardless of genotype. Evidence: mixed.","area":"gesundheit","canonical_id":"gesundheit:canonical-9bdca18f99f4723fb8929a39","id":"public-0729eed5b7f593255da7db0b","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of Sport","score":20.80821598,"snippet":"CYP1A2 is the primary enzyme responsible for caffeine metabolism. The common variant rs762551 (often called *1F) classifies individuals as fast (AA) or slow (AC/CC) metabolizers. In sports, it is hypothesized that fast metabolizers gain greater ergogenic benefit from caffeine, while slow metabolizers may face increased side effects like palpitations or sleep disruption. However, the evidence is mixed: some studies report improved endurance performance in AA homozygotes, but others find no genotype-dependent effect. Additionally, CYP1A2 activity is influenced by smoking, medications, and diet, which limits the predictive value of a single DNA test. Recent reviews (e.g., PMID: 30926990) conclu","sources":[],"title":"Evidence check: CYP1A2 in the context of Sport","url":"https://tikki.wiki/wissen/gesundheit/frage/public-0729eed5b7f593255da7db0b/evidence-check-cyp1a2-in-the-context-of-sport/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The role of CYP1A2 in longevity is not yet clearly established. CYP1A2 is a cytochrome P450 enzyme involved in caffeine metabolism and the activation/detoxification of various xenobiotics. Some GWAS have suggested associations between CYP1A2 variants and lifespan, possibly through altered carcinogen metabolism or oxidative stress regulation. However, effect sizes are small and context-dependent (e.g., coffee consumption, smoking). The evidence is best described as 'gwas' or 'mechanistic' – there are statistical associations but limited causal validation. Direct-to-consumer genetic tests often report CYP1A2 variants (e.g., rs762551) with claims about caffeine metabolism, but extrapolating to longevity is speculative. A conservative approach is warranted: do not make lifestyle changes based solely on this SNP. Safety note: altering caffeine intake based on genetics alone may have unintended health effects. For longevity, focus on established modifiable factors (diet, exercise, sleep) rather than single gene variants.","area":"gesundheit","canonical_id":"gesundheit:canonical-6c606a36af78f197cc36e2bc","id":"public-ccf46331884b62ef169cc39e","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of Langlebigkeit","score":20.63875385,"snippet":"The role of CYP1A2 in longevity is not yet clearly established. CYP1A2 is a cytochrome P450 enzyme involved in caffeine metabolism and the activation/detoxification of various xenobiotics. Some GWAS have suggested associations between CYP1A2 variants and lifespan, possibly through altered carcinogen metabolism or oxidative stress regulation. However, effect sizes are small and context-dependent (e.g., coffee consumption, smoking). The evidence is best described as 'gwas' or 'mechanistic' – there are statistical associations but limited causal validation. Direct-to-consumer genetic tests often report CYP1A2 variants (e.g., rs762551) with claims about caffeine metabolism, but extrapolating to ","sources":[],"title":"Evidence check: CYP1A2 in the context of Langlebigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-ccf46331884b62ef169cc39e/evidence-check-cyp1a2-in-the-context-of-langlebigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The link between CYP1A2 and stress is indirect, mediated by caffeine metabolism. CYP1A2 is the primary enzyme that breaks down caffeine. Genetic variants (e.g., rs762551) classify individuals as fast or slow caffeine metabolizers. Slow metabolizers experience prolonged caffeine exposure, which can amplify cortisol release and heighten anxiety or stress responses. However, the evidence is limited: no robust clinical trials directly connect CYP1A2 genotype to chronic stress or HPA axis recovery. Most support comes from mechanistic plausibility and small observational studies. Consumer DNA tests like MyBody-X may report this variant, but the real-world impact on daily stress is uncertain. High caffeine intake in slow metabolizers may disrupt sleep and increase tension. Be cautious of overblown claims: a single gene test cannot diagnose stress levels. For persistent stress, seek medical evaluation and use genetic data as a minor piece of the puzzle, not a standalone answer.","area":"gesundheit","canonical_id":"gesundheit:canonical-285687ccf53beb4f65b891dc","id":"public-c2b444c088062906e2aa59f4","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of Stress","score":20.52490771,"snippet":"The link between CYP1A2 and stress is indirect, mediated by caffeine metabolism. CYP1A2 is the primary enzyme that breaks down caffeine. Genetic variants (e.g., rs762551) classify individuals as fast or slow caffeine metabolizers. Slow metabolizers experience prolonged caffeine exposure, which can amplify cortisol release and heighten anxiety or stress responses. However, the evidence is limited: no robust clinical trials directly connect CYP1A2 genotype to chronic stress or HPA axis recovery. Most support comes from mechanistic plausibility and small observational studies. Consumer DNA tests like MyBody-X may report this variant, but the real-world impact on daily stress is uncertain. High ","sources":[],"title":"Evidence check: CYP1A2 in the context of Stress","url":"https://tikki.wiki/wissen/gesundheit/frage/public-c2b444c088062906e2aa59f4/evidence-check-cyp1a2-in-the-context-of-stress/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}